Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An update from the director of the Basic Science, Vaccines and Cure Project at Treatment Action Group (TAG).
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
Research shows that CAR-T cells could one day help cure HIV in humans.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
This finding stands in sharp contrast to a controversial 2016 paper that reached the opposite conclusion.
Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.
Sharon Lewin and Mark Dybul replace Jack Whitescarver and Françoise Barré-Sinoussi as cochairs of the advisory board.
The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.
Researchers discovered that higher levels of such cells were tied not only to infection risk but also HIV disease progression.
At stake in amfAR’s civil war is the nonprofit’s quest to find a cure for HIV.
This NIH study closely monitored 10 people with HIV who stopped antiretroviral treatment for weeks to months in a larger cure study.
CAR-T cells, which have recently made waves in the cancer field, may one day be the basis of a cure for HIV in humans.
Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.
The small trial nevertheless provided researchers with clues to help in their quest for treatments that prompt viral remission.
Scientists reached this finding thanks to a highly precise means of sequencing HIV’s genetics.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.